News & Events

11th Global Summit and Expo on Vaccines, Vaccination and Therapeutics

August 18, 2016

Charles Arntzen, Ph.D., Interim Co-director, Biodesign Center for Infectious Diseases and Vaccinology to present a keynote on “Design and Production of Anti-Ebola Vaccines and Therapeutics” and Stephen Albert Johnston, Ph.D., Director, Biodesign Center for Innovations in Medicine, to present a keynote on “Progress Towards a Universal, Preventative Cancer Vaccine” >>Visit conference website 

Fostering North American partnerships

August 16, 2016

Sethuraman "Panch" Panchanathan (left), senior vice president for ASU's Knowledge Enterprise Development; Joshua LaBaer, an executive with the Biodesign Institute; and Luis Armando Kuroda of Mexico's Salud Digna and Fundación Vizcarra (right) sign a memorandum of understanding (MOU) on Aug. 15. The MOU establishes a commitment to collaborate using ASU's undergraduate and graduate scientific researchers and Salud Digna's preventative health-care services with the goal of bringing greater...

Updates in Noninvasive Saliva Collection for Transcriptomics, Genomics and Proteomics in Oncology and Liquid Biopsy

June 16, 2016

Paul Slowey, Ph.D., CEO, Oasis Diagnostics Corporation Learn about new technologies available for noninvasive sample collection with applications for genomic assays in oncology and more. This seminar is hosted by Stephen Albert Johnston, Ph.D., ASU Biodesign Center for Innovations in Medicine. Iced tea, coffee and snacks will be provided. 

A Vaccine to Prevent Cancer in Dogs and People

June 9, 2016

Stephen Albert Johnston, Ph.D., Director, Biodesign Center for Innovations in Medicine   The common mutations across many tumors that have been identified are being tested in a new vaccine to prevent cancer in dogs. If it works in dogs with osteosarcoma, the vaccine could gain FDA approval for clinical trials for children with the same type of cancer by the end of the year.   This is a Spirit of the Senses salon. Members and Biodesign employees (and their guests) are welcome to...

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

ASU spinout aims to shake up the health care status quo

March 16, 2016

Editor’s note: HealthTell recently completed a $40 million capital campaign. The company, a spinout of ASU's Biodesign Institute with a nearby manufacturing facility in Chandler, Ariz., is poised to enter the big leagues as “one of the top 5 startups to watch” in the highly competitive health care diagnostics arena. With HealthTell's funding milestone completed, we've taken the opportunity to look back at the high-risk, adventurous beginnings a decade...

New 'cancer moonshot:' legit, or political rhetoric?

January 15, 2016

A "cancer moonshot" has been a hot topic ever since the nation first heard President Obama's proposal during his State of the Union address on Tuesday. This newest inspiration, in part, may have been from vice-president Joe Biden, whose son Beau died of brain cancer last year. But for the countless families that have also been affected by cancer, they have heard this federal promise before, under a different rhetoric dating back 4 decades ago to...

Earlier stage melanoma diagnosis advances with gift from Alliance Beverage

December 30, 2015

If you play golf, an already vexing game may throw another unexpected bogey---you may have an increased chance of getting skin cancer. Fred Couples has had numerous bouts with it, as has Hank Haney, Adam Scott and others. Half of all melanoma deaths in the U.S. are in men over age 50 – and melanoma is one of only three cancers for which mortality in men is increasing. The American Cancer Society predicts there will be 1,400 new cases in Arizona this year alone. Screening and early...

Biodesign teams up to develop early screening test for pediatric brain cancer

November 3, 2015

Biodesign Institute at Arizona State University researcher Stephen Albert Johnston, Ph.D., has partnered with leading researchers to boost efforts to develop a simple blood test for the early detection of pediatric brain cancer.  The underpinnings of the test rely on a powerful sentinel to detect foreign invaders in the body: the immune system.  “When sensing a tumor, the immune system tries to mount an attack using antibodies that recognize unique molecules produced...

Biodesign's Stephen Albert Johnston weighs in on Theranos media scrutiny

October 20, 2015

Theranos, a startup offering low-cost tests that require just a few drops of blood and screen for everything from cholesterol to cancer, has drawn national attention and is now valued at $9 billion. Recent news media reports, however, have scrutinized the company’s technology and the accuracy of its tests. Stephen Albert Johnston, co-director of the Center of Innovations in Medicine at Arizona State University’s Biodesign Institute says the company has made breakthroughs but also has...